TickerFacts.

Biomerica Inc (BMRA): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-05-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$362.0K
Year ended 2026-05-31
-6.7%
3-year compound annual growth
-0.2%
5-year compound annual growth
$2.98M2011-05-31: $1.53M2012-05-31: $2.30M2013-05-31: $2.43M2014-05-31: $1.67M2015-05-31: $1.54M2016-05-31: $1.52M2017-05-31: $2.02M2018-05-31: $1.75M2019-05-31: $1.29M2020-05-31: $1.74M2021-05-31: $366.3K2022-05-31: $2.98M2023-05-31: $446.0K2024-05-31: $611.0K2025-05-31: $498.0K2026-05-31: $362.0K$362.0K
2011-05-31 Gross Profit (USD) 2026-05-31
Period endedGross ProfitChange YoYSource filing
2026-05-31$362.0K-27.3%2026-08-31, From 2025-06-01
2025-05-31$498.0K-18.5%2026-08-31, From 2024-06-01
2024-05-31$611.0K+37.0%2025-08-29, From 2023-06-01
2023-05-31$446.0K-85.0%2024-08-28, From 2022-06-01
2022-05-31$2.98M+712.8%2023-08-25, From 2021-06-01
2021-05-31$366.3K-78.9%2022-08-29, From 2020-06-01
2020-05-31$1.74Mn/c2021-10-14, From 2019-06-01
2019-05-31$1.29M-26.4%2020-08-31, From 2018-06-01
2018-05-31$1.75M-13.2%2019-08-29, From 2017-06-01
2017-05-31$2.02M+32.7%2018-08-29, From 2016-06-01
2016-05-31$1.52M-1.2%2017-08-29, From 2015-06-01
2015-05-31$1.54M-7.6%2016-08-29, From 2014-06-01
2014-05-31$1.67M-31.2%2015-08-31, From 2013-06-01
2013-05-31$2.43M+5.7%2014-08-29, From 2012-06-01
2012-05-31$2.30M+50.6%2013-08-29, From 2011-06-01
2011-05-31$1.53Mn/a2012-08-29, From 2010-06-01

Gross Profit at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Biomerica Inc (BMRA)2026-05-31$362.0K-27.3%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$2.30M+210.5%
Anbio Biotechnology (NNNN)2025-12-31$7.54M+28.2%
Aspira Women's Health Inc. (AWHL)2025-12-31$5.92M+8.0%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$1.34Mn/a
Immucell Corp (ICCC)2025-12-31$11.45M+44.1%
Alpha Teknova, Inc. (TKNO)2025-12-31$13.44M+85.9%
Myriad Genetics Inc (MYGN)2025-12-31$576.60M-1.5%
Neogen Corp (NEOG)2026-05-31$408.50M-3.1%

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗